Latest Cambridge News | Page 11

Lynparza reduced risk of death by 32% in adjuvant treatment of patients with germline BRCA-mutated high-risk early breast cancer
Update on US regulatory review of Fasenra in chronic rhinosinusitis with nasal polyps
Lynparza approved in US as adjuvant treatment for patients with germline BRCA-mutated HER2-negative high-risk early breast cancer
Notice of Road Closure – Anzac Day
Council to purchase 150 Cambridge Road, Kilsyth
Merging neutron stars: unfolding story of kilonova told in X-rays
AstraZeneca and Neurimmune close exclusive global collaboration and licence agreement to develop and commercialise NI006
Ultomiris Now Available on PBS to treat Paroxysmal Nocturnal Haemoglobinuria
Auction Notice – Land to be sold 18 March 2022
Man charged as investigation continues into importation and manufacture of 3D-printed firearms, NSW
English language education set to help stimulate Australia’s economy
English language education set to help stimulate Queensland’s economy
NZ police release name over Levin crash 25 February
Received & Determined Development Applications 23 February
Fatality confirmed after Levin crash
Nirsevimab EMA regulatory submission accepted under accelerated assessment for RSV protection in all infants
Saphnelo approved in EU for treatment of moderate to severe systemic lupus erythematosus
Designer clothes and shoes worth $150,000 seized; three men charged over extortion offences, NSW
University of Toronto prof explores turbulent history of Caribbean in new literature seminar
Book explores free will or determinism debate
New cohort of international doctoral talent will tackle challenges of contemporary industry
Council proposes purchase of land at 150 Cambridge Road, Kilsyth
Six significant grants to solve world’s biggest killer – cardiovascular disease
How our genes influence our gut health
Male carriers of BRCA1 and BRCA2 gene mutation also at risk of multiple cancers: study
Is AI ageist? Researchers examine impact of technology on older users
David Williamson Receives 2022 Steele Prize from American Mathematical Society
As Omicron Cases Skyrocket, Extreme Marquees is Working on Medical Tents on War Footing
Bold bittern bucks trend, strikes pose in backyard
Imfinzi plus chemotherapy reduced risk of death by 20% in 1st-line advanced biliary tract cancer
Imfinzi plus tremelimumab demonstrated unprecedented survival in 1st-line unresectable liver cancer with 31% of patients alive
Development of fatty liver disease under healthy diet
Creating Reference Map to Explore Electronic Device Mimicking Brain Activity
AstraZeneca aims to redefine liver, biliary tract and prostate cancer treatment with practice-changing Imfinzi and Lynparza data
AstraZeneca and Scorpion Therapeutics enter agreement to discover, develop and commercialise novel cancer treatments against
Machine learning illuminates genetic links between blood cells and disease
AstraZeneca and Neurimmune sign exclusive global collaboration and licence agreement to develop and commercialise NI006
Transfer of global rights for Eklira and Duaklir to Covis Pharma completed
Tokyo Tech Academy of Energy and Informatics holds online kick-off ceremony, workshop
New book upends thinking on why people have ‘bad beliefs’
AstraZeneca and Ionis close agreement to develop and commercialise eplontersen
Blueprint Reveals How Plants Build Sugar Transport Lane
Vaxzevria significantly boosted antibody levels against Omicron
Evusheld long-acting antibody combination retains neutralising activity against Omicron variant 23 December
Ultomiris regulatory submission accepted under FDA Priority Review
Fourth man charged over abduction and home invasion at Sans Souci, NSW
Saphnelo recommended for approval in EU by CHMP for treatment of patients with systemic lupus erythematosus
Tezspire approved in US for severe asthma